reformulate [Design Issues]

posted by Dr_Dan  – Germany, 2015-03-04 09:56 (4133 d 11:39 ago) – Posting: # 14545
Views: 18,751

Dear Mei San

During the development of a medicinal product the dissolution test is used as a tool to identify formulation factors that are influencing and may have a crucial effect on the bioavailability of the drug. You can argue that in the event that the results of comparative in vitro dissolution of the biobatches do not reflect bioequivalence as demonstrated in vivo the latter prevails. However, possible reasons for the discrepancy should be addressed and justified and honestly, I wouldn't try a study if comparative in vitro dissolution shows such demoralizing results.
As you learned so far in your case BE will be tricky and variability will be high. And then you will start with such a formulation? Forget it!

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
354 visitors (0 registered, 354 guests [including 15 identified bots]).
Forum time: 22:35 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5